Hardy Reed
AZN icon

Hardy Reed’s AstraZeneca AZN Stock Holding History

Hardy Reed’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$424K Buy
2,623
+127
+5% +$21.2K 0.03% 180
2026
Q2 		$473K Sell
2,496
-6
-0.2% -$1.13K 0.03% 158
2026
Q1 		$493K Buy
2,502
+601
+32% +$116K 0.04% 145
2025
Q4 		$349K Buy
1,901
+52
+3% +$9.12K 0.02% 182
2025
Q3 		$284K Buy
1,849
+180
+11% +$27.2K 0.02% 200
2025
Q2 		$233K Buy
1,669
+37
+2% +$5.19K 0.02% 221
2025
Q1 		$240K Buy
1,632
+36
+2% +$5.21K 0.02% 209
2024
Q4 		$209K Buy
1,596
+5
+0.3% +$700 0.02% 240
2024
Q3 		$248K Buy
1,591
+89
+6% +$14.4K 0.02% 213
2024
Q2 		$234K Buy
+1,502
New +$226K 0.02% 207

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Hardy Reed's AZN Position: Q3 2026 in Review

Hardy Reed increased its AstraZeneca (AZN) stake by 5.1% in Q3 2026, buying an estimated $21.2K and bringing the position to 2,623 shares worth $424K. The position accounts for 0.03% of the portfolio, ranked #180.

Hardy Reed first reported a position in AZN in Q2 2024 and has held it in 10 quarters since. The position peaked at $493K in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Hardy Reed held 2,623 shares of AstraZeneca worth $424K as of Q3 2026.
  • Hardy Reed bought 127 AstraZeneca shares in Q3 2026, an estimated $21.2K.
  • AstraZeneca made up 0.03% of Hardy Reed's portfolio in Q3 2026, its #180 holding.
  • Hardy Reed first reported a position in AstraZeneca in Q2 2024 and has held it in 10 quarters since.
  • Hardy Reed's AstraZeneca position peaked at $493K in Q1 2026.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.